| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2858411320fb0a2e0a846742666185f9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2013-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac60b27775cae9960b0798ee6ba2766f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1194275b2d16da991201b2008ae979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0027dfe524a7995cac09b2cdc5ae13bc |
| publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014023923-A3 |
| titleOfInvention |
Treatment of osteoarthritis with incretin hormones or analogues thereof |
| abstract |
The invention relates to the use of glucagon-like peptide-1 (GLP-1) incretin hormones and glucose-dependent insulinotropic peptide (GIP) and the analogues thereof, in particular analogues resistant to dipeptidyl peptidase IV, in the treatment of osteoarthritis, in particular to inhibit or slow down the destruction of cartilage. |
| priorityDate |
2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |